Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer

Carcinogenesis

Volumn 33, Issue 1, 2012, Pages 203-208

  Mabrok, Hoda B ^a,b   Klopfleisch, Robert ^c   Ghanem, Kadry Z ^b   Clavel, Thomas ^d   Blaut, Michael ^a   Loh, Gunnar ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GLUTATHIONE; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGNAN; MALONALDEHYDE; SECOISOLARICIRESINOL DIGLUCOSIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INCIDENCE; CANCER SIZE; CELL PROLIFERATION; CLOSTRIDIUM; CONTROLLED STUDY; DEGRADATION; DIET; EGGERTHELLA LENTA; FEMALE; GENE EXPRESSION; INTESTINE FLORA; LINSEED; LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TISSUE LEVEL; TUMOR GROWTH;

EID: 84855413278     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr256     Document Type: Article

References (45)

1. Jemal,A. et al. (2011) Global cancer statistics. CA Cancer J. Clin., 61, 69-90.
2. Key,T. et al. (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl Cancer Inst., 94, 606-616.
3. Adlercreutz,H. (2002) Phyto-oestrogens and cancer. Lancet Oncol., 3, 364-373.
4. Adlercreutz,H. (2007) Lignans and human health. Crit. Rev. Clin. Lab. Sci., 44, 483-525.
5. Thompson,L.U. et al. (1996) Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis, 17, 1373-1376.
6. Serraino,M. et al. (1992) Flaxseed supplementation and early markers of colon carcinogenesis. Cancer Lett., 63, 159-165.
7. Thompson,L.U. et al. (1996) Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr. Cancer, 26, 159-165.
8. Rickard,S.E. et al. (1999) Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr. Cancer, 35, 50-57.
9. Clavel,T. et al. (2006) Bioavailability of lignans in human subjects. Nutr. Res. Rev., 19, 187-196.
10. Pietinen,P. et al. (2001) Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol. Biomarkers Prev., 10, 339-344.
11. Ingram,D. et al. (1997) Case-control study of phyto-oestrogens and breast cancer. Lancet, 350, 990-994.
12. Power,K.A. et al. (2006) Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice. Int. J. Cancer, 118, 1316-1320.
13. Clavel,T. et al. (2006) Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. Anaerobe, 12, 140-147.
14. Woting,A. et al. (2010) Bacterial transformation of dietary lignans in gnotobiotic rats. FEMS Microbiol. Ecol., 72, 507-514.
15. Becker,N. et al. (2011) Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model. Gut Microbes, 2, 25-33.
16. Aebi,H. (1984) Catalase in vitro. Methods Enzymol., 105, 121-126.
17. Beauchamp,C. et al. (1971) Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal. Biochem., 44, 276-287.
18. Mannervik,B. et al. (1981) Glutathione transferase (human placenta). Methods Enzymol., 77, 231-235.
19. Ellman,G.L. (1959) Tissue sulfhydryl groups. Arch. Biochem. Biophys., 82, 70-77.
20. Mihara,M. et al. (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem., 86, 271-278.
21. Bradford,M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
22. Velentzis,L.S. et al. (2009) Lignans and breast cancer risk in pre- and postmenopausal women: meta-analyses of observational studies. Br. J. Cancer, 100, 1492-1498.
23. McCann,S.E. et al. (2010) Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res. Treat., 122, 229-235.
24. Ward,H.A. et al. (2010) Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am. J. Clin. Nutr., 91, 440-448.
25. Hedelin,M. et al. (2008) Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J. Nutr., 138, 938-945.
26. Sonestedt,E. et al. (2010) Enterolactone and breast cancer: methodological issues may contribute to conflicting results in observational studies. Nutr. Res., 30, 667-677.
27. Kurzer,M.S. et al. (1995) Fecal lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Cancer Epidemiol. Biomarkers Prev., 4, 353-358.
28. Kuijsten,A. et al. (2005) Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J. Nutr., 135, 795-801.
29. Saarinen,N.M. et al. (2000) Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr. Cancer, 36, 207-216.
30. Saarinen,N.M. et al. (2008) Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats. Int. J. Cancer, 123, 1196-1204.
31. Schultze-Mosgau,M.H. et al. (1998) Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells. Eur. J. Cancer, 34, 1425-1431.
32. Fabian,C.J. et al. (2010) Reduction in Ki-67 in benign breast tissue of highrisk women with the lignan secoisolariciresinol diglycoside. Cancer Prev. Res. (Phila), 3, 1342-1350.
33. Webb,A.L. et al. (2005) Dietary lignans: potential role in cancer prevention. Nutr. Cancer, 51, 117-131.
34. Saggar,J.K. et al. (2010) The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways. Nutr. Cancer, 62, 533-542.
35. Chen,J. et al. (2009) Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice. J. Nutr., 139, 2061-2066.
36. Penttinen,P. et al. (2007) Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology, 148, 4875-4886.
37. Chen,J. et al. (2007) Flaxseed alone or in combination with tamoxifen inhibitsMCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp. Biol. Med. (Maywood), 232, 1071-1080.
38. Chen,J. et al. (2007) Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways. Nutr. Cancer, 58, 162-170.
39. Kitts,D.D. et al. (1999) Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol. Cell Biochem., 202, 91-100.
40. Prasad,K. (1997) Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed. Mol. Cell Biochem., 168, 117-123.
41. Prasad,K. (2000) Antioxidant activity of secoisolariciresinol diglucosidederived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int. J. Angiol., 9, 220-225.
42. Yuan,Y.V. et al. (1999) Short-term feeding of flaxseed or its lignan has minor influence on in vivo hepatic antioxidant status in young rats. Nutr. Res., 19, 1233-1243.
43. Scharlau,D. et al. (2009) Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat. Res., 682, 39-53.
44. Yonezawa,T. et al. (2007) Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. Cell. Signal., 19, 185-193.
45. Kleessen,B. et al. (1997) Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acids in rats. J. Anim. Sci., 75, 2453-2462.